2020
DOI: 10.1097/rmr.0000000000000237
|View full text |Cite
|
Sign up to set email alerts
|

Deep Learning AI Applications in the Imaging of Glioma

Abstract: This manuscript will review emerging applications of artificial intelligence, specifically deep learning, and its application to glioblastoma multiforme (GBM), the most common primary malignant brain tumor. Current deep learning approaches, commonly convolutional neural networks (CNNs), that take input data from MR images to grade gliomas (high grade from low grade) and predict overall survival will be shown. There will be more in-depth review of recent articles that have applied different CNNs to predict the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
40
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 60 publications
(49 citation statements)
references
References 36 publications
0
40
0
Order By: Relevance
“…Computer science leading the incorporation of artificial intelligence into clinical nomograms to generate integrative systems for medicine is changing our approaches to analyze large-scale and complex datasets. Machine learning algorithms are already changing the field of cancer diagnosis and prognosis by exploring diverse data types, including imaging, histology, and multi-omics, to efficiently classify various clinically relevant GBM traits [ 85 88 ]. These advances will undoubtedly bring novel and more personalized diagnostic and therapeutic alternatives for patients with GBM.…”
Section: Discussionmentioning
confidence: 99%
“…Computer science leading the incorporation of artificial intelligence into clinical nomograms to generate integrative systems for medicine is changing our approaches to analyze large-scale and complex datasets. Machine learning algorithms are already changing the field of cancer diagnosis and prognosis by exploring diverse data types, including imaging, histology, and multi-omics, to efficiently classify various clinically relevant GBM traits [ 85 88 ]. These advances will undoubtedly bring novel and more personalized diagnostic and therapeutic alternatives for patients with GBM.…”
Section: Discussionmentioning
confidence: 99%
“…Recent developments in advanced MR and PET scanning have improved CNS imaging, up to the point that now we can collect specific information within brain TME compartments [ 105 , 106 , 107 ]. Nevertheless, a careful histo-morphological evaluation of tumour tissue by pathologists is still of fundamental importance, and features such as Scherer’s secondary structures are still a valuable clue into the diagnosis of diffuse, possibly high-grade gliomas.…”
Section: Discussionmentioning
confidence: 99%
“…Recent developments in advanced MR and PET scanning have improved CNS imaging, up to the point that now we can collect specific information within brain TME compartments [110][111][112]. Nevertheless, a careful histo-morphological evaluation of tumour tissue by pathologists is still of GB cells interact with BBB:…”
Section: Discussionmentioning
confidence: 99%